FDA Adverse Event Other Summary report: N

NICOLETONE VEEG 44 CHANNEL ETERNET DIGITAL VI

MDR report key: 2485177 · Received March 7, 2012

Report

Report Number
3008289288-2010-00001
Event Type
Other
Date Received
March 7, 2012
Date of Event
February 2, 2010
Report Date
March 3, 2010
Manufacturer
CAREFUSION 209 INC.
Product Code
GWQ
PMA / PMN Number
K991054
Removal / Correction Number
2126317/03/02/2010/001-C
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NY, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

FOR UNITS IN THE FIELD, WE WILL NOTIFY USERS ABOUT THE R/L PROTOCOLS AND INSTRUCT THEM TO BE REMOVED FROM THE PROTOCOLS MENU IF THEY ARE NOT UTILIZED AND PROPERLY UNDERSTAND BY THE USER FACILITY AND STAFF. ONE PT UNDERWENT BILATERAL ELECTRODE GRID PLACEMENT WHEN UNILATERAL GRID PLACEMENT MAY HAVE SUFFICED. THE USER FACILITY ALSO SUBMITTED A MEDWATCH REPORT (B)(4). THIS REPORT WAS EDITED ON 3/6/2012 TO REVISE THE REGISTRATION NUMBER FROM 2126317 TO 3008289288. THE CURRENT REGISTRATION NUMBER WAS NOT KNOWN AT THE TIME THE INITIAL MDR WAS SENT.

Description of Event or Problem · 1

A CUSTOMER COMPLAINT WAS RECEIVED INDICATING THAT THE USER HAD DISCOVERED THAT EEG DATA FROM ELECTRODES PLACED ON THE RIGHT SIDE OF THE HEAD DISPLAYED IN THE EEG RECORD AS HAVING COME FROM THE LEFT SIDE OF THE HEAD AND VISA VERSA. INVESTIGATION DETERMINED THAT THE CUSTOMER SELECTION AND USE OF THE "ROUTINE V44 R/L" PROTOCOL (R/L REFERS TO THE RIGHT SIDE ELECTRODES DISPLAYED OVER THE LEFT SIDE ELECTRODES) WITHOUT THE ASSOCIATED AMPLIFIER OVERLAY MAY RESULT IN A MISMATCH BETWEEN THE AMPLIFIER LABELING AND THE PROTOCOL. THIS MAY RESULT IN THE MISINTERPRETATION OF THE LEFT VERSUS RIGHT SIDE OF THE BRAIN. IN ONE CASE, A PT UNDERWENT BILATERAL GRID PLACEMENT SURGERY WHEN UNILATERAL GRID PLACEMENT WOULD HAVE SUFFICED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 NICOLETONE VEEG 44 CHANNEL ETERNET DIGITAL VI NICOLETONE GWQ CAREFUSION 209 INC.

Patients

Seq Age Sex Outcome Treatment
1 NA Other EVALUATED ON CUSTOMER SITE.